Trials / Completed
CompletedNCT04181697
HemFitBit, an Observational Study of Physical Activity in People With Moderate and Severe Haemophilia A
The HemFitBit-study: Defining Normal Physical Activity in Haemophilia A
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- Male
- Age
- 13 Years – 30 Years
- Healthy volunteers
- —
Summary
The study aims to describe physical activity (PA) levels in young people with haemophilia A in Norway compared with non-haemophilia controls, and to identify factors influencing PA. This will be conducted through an observational study measuring PA over 12 weeks. Forty young people with moderate and severe haemophilia A will be enrolled. PA data will be compared to demographically and seasonally matched non-haemophilia controls. PA will be measured using the activity tracker Fitbit Charge 3. A subgroup of participants will also wear the hip-worn accelerometer ActiGraph GTX+BT for seven consecutive days in order to validate the two devices against each other.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PA measurement with Fitbit Charge 3 | Measurement of PA with Fitbit for all participants and controls. |
| DEVICE | PA measurement with Fitbit and ActiGraph GT3X | Measurement of PA with ActiGraph for a subgroup of 20 participants. |
Timeline
- Start date
- 2019-11-05
- Primary completion
- 2020-08-27
- Completion
- 2020-08-27
- First posted
- 2019-11-29
- Last updated
- 2020-11-30
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT04181697. Inclusion in this directory is not an endorsement.